BAJAJ BROKING

Notification
No new Notification messages
One Mobikwik Systems IPO is Open!
Apply for the One Mobikwik Systems IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
vista pharmaceuticals ltd. stock

VISTA PHARMACEUTICALS LTD. Share Price

11.8 -0.06 (-0.50%)
Dec 11 2024 03:24 PM Pharmaceuticals NSE: VISTAPH

VISTA PHARMACEUTICALS LTD. Share Price Update

As of the latest trading session, VISTA PHARMACEUTICALS LTD. share price is currently at 11.8, which is down by -0.06 from its previous closing. Today, the stock has fluctuated between 11.30 and 11.87. Over the past year, VISTA PHARMACEUTICALS LTD. has achieved a return of -27.79 %. In the last month alone, the return has been -3.88 %. Read More...

VISTA PHARMACEUTICALS LTD. Performance

Day Range

Low11.30 High11.87
11.40

52 Week Range

Low 10.43 High 17.89
11.40

VISTA PHARMACEUTICALS LTD. Share Price

524711

VISTAPH

img img img img
No Data Available

Open Price

11.87

Prev. Close

11.87

Volume (Shares)

5173.00

Total traded value

.58

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

VISTA PHARMACEUTICALS LTD. Fundamentals


(Standalone)

Market Cap (Cr) 44.30
PE Ratio (TTM) -13.64
Book Value / Share 11.25
Beta 0.41
ROE 0.00%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -0.97

VISTA PHARMACEUTICALS LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 2.49
Operating Expense 3.75
Net Profit -0.97
Net Profit Margin (%) -38.95
Earnings Per Share (EPS) -0.16
EBITDA -0.82
Effective Tax Rate (%) 22.40
Particulars JUN 2024 (Values in Cr)
Revenue 1.80
Operating Expense 3.03
Net Profit -0.86
Net Profit Margin (%) -47.77
Earnings Per Share (EPS) -0.15
EBITDA -0.71
Effective Tax Rate (%) 26.49
Particulars MAR 2024 (Values in Cr)
Revenue 3.13
Operating Expense 3.33
Net Profit 0.09
Net Profit Margin (%) 2.87
Earnings Per Share (EPS) 0.02
EBITDA 0.36
Effective Tax Rate (%) 190.00
Particulars DEC 2023 (Values in Cr)
Revenue 1.70
Operating Expense 3.92
Net Profit -1.63
Net Profit Margin (%) -95.88
Earnings Per Share (EPS) -0.33
EBITDA -1.72
Effective Tax Rate (%) 25.90
Particulars SEP 2023 (Values in Cr)
Revenue 3.47
Operating Expense 5.14
Net Profit -2.02
Net Profit Margin (%) -58.21
Earnings Per Share (EPS) -0.46
EBITDA -1.09
Effective Tax Rate (%) -27.04
Particulars MAR 2024 (Values in Cr)
Revenue 10.29
Operating Expense 15.80
Net Profit -4.51
Net Profit Margin (%) -43.82
Earnings Per Share (EPS) -1.03
EBITDA -3.24
Effective Tax Rate (%) 12.93
Particulars MAR 2023 (Values in Cr)
Revenue 1.00
Operating Expense 7.28
Net Profit -5.66
Net Profit Margin (%) -566.00
Earnings Per Share (EPS) -1.54
EBITDA -4.05
Effective Tax Rate (%) 3.57
Particulars MAR 2022 (Values in Cr)
Revenue 0.39
Operating Expense 3.12
Net Profit -0.83
Net Profit Margin (%) -212.82
Earnings Per Share (EPS) -0.24
EBITDA -1.04
Effective Tax Rate (%) 67.57
Particulars MAR 2021 (Values in Cr)
Revenue 1.27
Operating Expense 5.27
Net Profit -2.01
Net Profit Margin (%) -158.26
Earnings Per Share (EPS) -0.54
EBITDA -1.52
Effective Tax Rate (%) 47.24
Particulars MAR 2020 (Values in Cr)
Revenue 22.76
Operating Expense 30.43
Net Profit -3.68
Net Profit Margin (%) -16.16
Earnings Per Share (EPS) -1.22
EBITDA -1.04
Effective Tax Rate (%) 6.59
Particulars MAR 2024 (Values in Cr)
Book Value / Share 7.56
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.23
EBITDA Margin -31.29
Particulars MAR 2023 (Values in Cr)
Book Value / Share 8.13
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.31
EBITDA Margin -392.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 9.64
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.34
EBITDA Margin -282.05
Particulars MAR 2021 (Values in Cr)
Book Value / Share 8.93
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.42
EBITDA Margin -120.47
Particulars MAR 2020 (Values in Cr)
Book Value / Share 9.76
ROE % -11.25
ROCE % -5.21
Total Debt to Total Equity 0.41
EBITDA Margin -4.61
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.09
Total Assets 57.97
Total Liabilities 57.97
Total Equity 40.46
Share Outstanding 47164899
Price to Book Ratio 1.41
Return on Assets (%) -7.78
Return on Capital (%) -9.32
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.20
Total Assets 56.02
Total Liabilities 56.02
Total Equity 36.70
Share Outstanding 37556639
Price to Book Ratio 1.03
Return on Assets (%) -10.10
Return on Capital (%) -12.13
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.07
Total Assets 55.58
Total Liabilities 55.58
Total Equity 35.45
Share Outstanding 36793907
Price to Book Ratio 0.96
Return on Assets (%) -1.59
Return on Capital (%) -1.85
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.14
Total Assets 50.85
Total Liabilities 50.85
Total Equity 32.84
Share Outstanding 36793907
Price to Book Ratio 1.01
Return on Assets (%) -3.94
Return on Capital (%) -4.61
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.22
Total Assets 51.12
Total Liabilities 51.12
Total Equity 29.64
Share Outstanding 30365337
Price to Book Ratio 0.54
Return on Assets (%) -7.19
Return on Capital (%) -8.15
Particulars MAR 2024 (Values in Cr)
Net Income -5.17
Cash from Operations -4.91
Cash from Investing -0.78
Cash from Financing 5.59
Net change in Cash -0.10
Free Cash Flow -4.12
Particulars MAR 2023 (Values in Cr)
Net Income -5.87
Cash from Operations -2.76
Cash from Investing -1.27
Cash from Financing 3.11
Net change in Cash 0.13
Free Cash Flow -1.49
Particulars MAR 2022 (Values in Cr)
Net Income -2.61
Cash from Operations -0.99
Cash from Investing -0.01
Cash from Financing 0.93
Net change in Cash -0.06
Free Cash Flow -0.97
Particulars MAR 2021 (Values in Cr)
Net Income -3.68
Cash from Operations -6.74
Cash from Investing -0.29
Cash from Financing 6.96
Net change in Cash -0.08
Free Cash Flow -6.44
Particulars MAR 2020 (Values in Cr)
Net Income -3.93
Cash from Operations 0.80
Cash from Investing -1.72
Cash from Financing 0.28
Net change in Cash -0.64
Free Cash Flow 1.04
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.90 37.87 3.59 505.01 37.54 / 77.70
BLISS GVS PHARMA LTD 155.50 19.46 1.62 1637.91 92.25 / 172.40
CIPLA LTD 1455.65 25.47 4.14 117560.12 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 414.95 144.08 4.20 1221.24 145.00 / 440.00
GLAXOSMITHKLINE PHARMA LT 2328.95 49.21 23.58 39453.82 1664.75 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.90 57.30 11.20 505.01 37.54 / 77.70
AMRUTAJAN HEALTH LTD 753.60 45.84 7.31 2178.71 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6634.15 128.84 24.41 16585.38 4050.15 / 8139.85
BLISS GVS PHARMA LTD 155.50 20.27 1.59 1637.91 92.25 / 172.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 11.70
  • 26 Days 12.00
  • 10 Days 11.80
  • 50 Days 12.40
  • 12 Days 11.80
  • 100 Days 13.00
  • 20 Days 11.90
  • 200 Days 15.10
11.75
PIVOT
First Resistance 12.09
Second Resistance 12.31
Third Resistance 12.65
First Support 11.53
Second Support 11.19
Third Support 10.97
RSI 47.19
MACD -0.26
Commodity Channel Index (CCI) -43.42
ADX 17.80
Williams % R -32.30

Over 1 Month

down

-3.88

Over 3 Months

down

-8.69

Over 6 Months

down

-10.41

Over 1 Year

down

-27.79

Over 3 Years

down

9.74

Over 5 Years

down

3.86

VISTA PHARMACEUTICALS LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

VISTA PHARMACEUTICALS LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
78.79
Promoter Holdings
21.18
FII
0.0
DII
0.02
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Murali Meraga Public Shareholding 9000000.0 14.62
Pavan Sathvik Gilaka Public Shareholding 7758000.0 12.6
Umakanth Katta Public Shareholding 7638413.0 12.41
Vista Pharmaceuticals Inc Shareholding of Promoter and Promoter Group 6579620.0 10.69
Dhananjaya Alli Shareholding of Promoter and Promoter Group 2887424.0 4.69
Suresh Gadalay Public Shareholding 2855604.0 4.64
Kamal Gadalay Public Shareholding 1801169.0 2.93
Vasant V Alli Shareholding of Promoter and Promoter Group 1601478.0 2.6
Deepthi Pachipala Public Shareholding 1500000.0 2.44
Chittajallu Naga Keerthi Public Shareholding 1500000.0 2.44
Keshava Murthy Shiva Shankar Public Shareholding 1255158.0 2.04
Andhra Pradesh Industrial Development Corporation Limited Shareholding of Promoter and Promoter Group 750000.0 1.22
Rajendar Balakrishna Public Shareholding 700000.0 1.14
Ramaswamy Reddy Pedinekaluva Public Shareholding 692017.0 1.12
Padmavathi Alli Shareholding of Promoter and Promoter Group 463666.0 0.75
Vamsi V Alli Shareholding of Promoter and Promoter Group 416666.0 0.68
Roshni Alli Shareholding of Promoter and Promoter Group 341333.0 0.55

VISTA PHARMACEUTICALS LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date
2015-06-25 10.0 2.0 2015-06-26

Learn More About Stocks

About VISTA PHARMACEUTICALS LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by VISTA PHARMACEUTICALS LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Vista Pharmaceuticals Ltd?

Answer Field

The share price of Vista Pharmaceuticals Ltd for NSE is ₹ 0.00 and for BSE is ₹ 11.40.

What is the Market Cap of Vista Pharmaceuticals Ltd?

Answer Field

The market cap of Vista Pharmaceuticals Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 44.30 Cr. as of now.

What is the 52 Week High and Low of Vista Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Vista Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 17.89 and ₹ 10.43.

How to Buy Vista Pharmaceuticals Ltd share?

Answer Field

You can trade in Vista Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Vista Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been -27.79%.

What is the Current Share Price of Vista Pharmaceuticals Ltd?

Answer Field

Vista Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 11.40 as on Dec 11 2024 03:24 PM.

What is the Market Cap of Vista Pharmaceuticals Ltd Share?

Answer Field

The market cap of Vista Pharmaceuticals Ltd for NSE ₹ 0.0 & for BSE ₹ 44.30 as on Dec 11 2024 03:24 PM.

What is the P/E Ratio of Vista Pharmaceuticals Ltd Share?

Answer Field

As on Dec 11 2024 03:24 PM the price-to-earnings (PE) ratio for Vista Pharmaceuticals Ltd share is -13.64.

What is the PB ratio of Vista Pharmaceuticals Ltd Share?

Answer Field

As on Dec 11 2024 03:24 PM, the price-to-book (PB) ratio for Vista Pharmaceuticals Ltd share is 11.25.

How to Buy Vista Pharmaceuticals Ltd Share?

Answer Field

You can trade in Vista Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Vista Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Vista Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Vista Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader